Skip to main content
. 2020 Feb 16;52(3):764–778. doi: 10.4143/crt.2020.044

Fig. 5.

Fig. 5.

Mutations between primary and metastatic tumors for a subgroup of 19 patients with M1 and M2 tumors. (A) Progression type according to synchronous and metachronous metastasis. (B) Heterogeneity according to synchronous and metachronous metastasis. (C) Variant changes of key genes in colorectal cancer between P, M1, and M2.